GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cardiff Oncology Inc (FRA:XE7C) » Definitions » Change In Other Working Capital

Cardiff Oncology (FRA:XE7C) Change In Other Working Capital : €0.06 Mil (TTM As of Jun. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Cardiff Oncology Change In Other Working Capital?

Cardiff Oncology's Change In Other Working Capital for the quarter that ended in Jun. 2024 was €-0.01 Mil. It means Cardiff Oncology's Other Working Capital declined by €0.01 Mil from Mar. 2024 to Jun. 2024 .

Cardiff Oncology's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was €0.08 Mil. It means Cardiff Oncology's Other Working Capital increased by €0.08 Mil from Dec. 2022 to Dec. 2023 .


Cardiff Oncology Change In Other Working Capital Historical Data

The historical data trend for Cardiff Oncology's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardiff Oncology Change In Other Working Capital Chart

Cardiff Oncology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Other Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.40 -0.59 -0.17 -0.99 0.08

Cardiff Oncology Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 - 0.09 -0.01 -0.01

Cardiff Oncology Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cardiff Oncology Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Cardiff Oncology's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Cardiff Oncology Business Description

Industry
Traded in Other Exchanges
Address
11055 Flintkote Avenue, San Diego, CA, USA, 92121
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").

Cardiff Oncology Headlines

No Headlines